MD
MeCo Diagnostics focuses on developing antifibrotic therapies, specifically targeting applications in breast cancer treatment. The company leverages proprietary technology and scientific research to create novel therapeutic approaches. Their work aims to unlock new treatment modalities for fibrotic conditions in oncology and beyond.
Updated 4 months ago
Funding
$810K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- MeCo Diagnostics focuses on developing antifibrotic therapies, specifically targeting applications in breast cancer treatment. The company leverages proprietary technology and scientific research to create novel therapeutic approaches. Their work aims to unlock new treatment modalities for fibrotic conditions in oncology and beyond.